Overview and Chemical Background

Methyl 2,3-dioxo-1,2,3,4-tetrahydroquinoxaline-6-carboxylate (SKU: M731215) is a member of the quinoxaline-2,3(1H,4H)-dione family, characterized by a benzene ring fused to a pyrazine ring bearing two carbonyl groups at positions 2 and 3. The additional methyl ester group at position 6 provides a handle for further functionalization, making this compound a valuable intermediate in the synthesis of biologically active molecules.

Quinoxalinedione scaffolds are well-recognized in pharmaceutical research for their broad biological relevance, including roles as AMPA/kainate receptor antagonists and as precursors to diverse nitrogen-containing heterocycles. The ester group at C-6 allows nucleophilic, condensation, and coupling reactions, extending the synthetic utility of this building block.

Safety and Handling Guidelines

Before working with Methyl 2,3-dioxo-1,2,3,4-tetrahydroquinoxaline-6-carboxylate, consult the Safety Data Sheet (SDS) provided with the product. Standard laboratory precautions should be followed at all times:

• Personal Protective Equipment (PPE): Wear appropriate gloves (nitrile recommended), safety goggles, and a laboratory coat when handling this compound.
• Ventilation: Handle the compound in a well-ventilated area or under a fume hood to minimize inhalation exposure to fine particulates.
• Skin and Eye Contact: Avoid direct contact. In case of skin or eye contact, rinse immediately with copious amounts of water and seek medical advice if irritation persists.
• Waste Disposal: Dispose of waste in accordance with local, regional, and national regulations for chemical waste.

Store the compound according to label instructions, typically in a cool, dry place away from direct sunlight and incompatible materials. Ensure containers are tightly sealed to prevent moisture uptake.

Solution Preparation and Solubility

Methyl 2,3-dioxo-1,2,3,4-tetrahydroquinoxaline-6-carboxylate is a solid at room temperature. Solubility information should be confirmed experimentally, as solubility can vary with lot and conditions. General guidance for solution preparation:

1. Solvent Selection: Polar aprotic solvents such as DMSO or DMF are commonly suitable for dissolving quinoxalinedione derivatives. Partial solubility may be observed in ethanol or acetonitrile. Aqueous solubility is expected to be limited; consult the SDS or technical data sheet for specific values.
2. Stock Solution Preparation: Weigh the required amount of compound using an analytical balance. Transfer to a clean, dry vial. Add the chosen solvent and mix thoroughly by vortexing or sonication until complete dissolution is achieved.
3. Filtration: If particulates remain, filter the solution through a 0.2 µm PTFE syringe filter before use.
4. Concentration Verification: For critical applications, verify solution concentration by UV-Vis spectrophotometry using the compound's characteristic absorption or by alternative validated analytical method.

Prepare fresh solutions where possible and store aliquots at appropriate temperatures as indicated in the product data sheet to preserve compound integrity.

Typical Synthetic and Research Applications

Methyl 2,3-dioxo-1,2,3,4-tetrahydroquinoxaline-6-carboxylate serves as a multifunctional intermediate in several research contexts:

• N-Alkylation and N-Acylation: The NH groups at positions 1 and 4 can be selectively or exhaustively alkylated or acylated to generate N-substituted quinoxalinedione libraries for structure–activity relationship (SAR) studies.
• Ester Hydrolysis and Amide Bond Formation: The methyl ester at C-6 can be hydrolyzed to the corresponding carboxylic acid, which can subsequently undergo amide coupling reactions with amines using standard peptide coupling reagents (e.g., EDC, HATU) to introduce diverse amino substituents.
• Reduction Reactions: Selective reduction of the ester group using appropriate reducing agents (e.g., LiAlH4 or DIBAL-H under controlled conditions) can yield the corresponding hydroxymethyl derivative, enabling further transformations.
• Condensation and Cyclization: The active carbonyl groups of the quinoxalinedione ring can participate in condensation reactions with nucleophilic reagents, enabling ring-opening or ring-transformation strategies toward novel heterocyclic systems.

These versatile reaction pathways make this compound an attractive starting material for combinatorial chemistry and medicinal chemistry programs targeting CNS, anti-infective, and other therapeutic areas.

Quality Control and Storage Recommendations

To ensure experimental reproducibility, users should verify compound identity and purity upon receipt and prior to critical experiments. Recommended quality control approaches include:

• Identity Confirmation: Use ¹H NMR or LC-MS to confirm molecular identity against the certificate of analysis (CoA) provided by Aladdin Scientific.
• Purity Assessment: HPLC analysis (reverse-phase C18 column, UV detection) is recommended to assess chemical purity. Compare against the purity specification stated on the CoA.
• Moisture Check: For moisture-sensitive applications, Karl Fischer titration may be employed to determine water content.

Storage Conditions: Store Methyl 2,3-dioxo-1,2,3,4-tetrahydroquinoxaline-6-carboxylate in a tightly sealed container in a cool, dry, and well-ventilated location. Protect from light and moisture. Refer to the product label and CoA for specific storage temperature recommendations. For long-term storage, consider desiccated conditions.

If the compound has been stored for an extended period, re-confirm identity and purity before use in sensitive assays.